Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review

BACKGROUND: Bevacizumab combined with fluorouracil is the currently recommended maintenance treatment for metastatic colorectal cancer, but the use of bevacizumab needs to be carried out in hospitals, which invisibly increases the risk of patients’ exposure to coronavirus disease 2019 (COVID-19) dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Ming, Chen, Zhiqin, Chen, Jingde, Hai, Yanan, Gao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660051/
https://www.ncbi.nlm.nih.gov/pubmed/36388683
http://dx.doi.org/10.21037/jgo-22-824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660051/
https://www.ncbi.nlm.nih.gov/pubmed/36388683
http://dx.doi.org/10.21037/jgo-22-824

Ejemplares similares